Related by context. All words. (Click for frequent words.) 73 alkylating agent 72 chemotherapeutic drug 70 erlotinib Tarceva 70 erlotinib Tarceva ® 69 DFMO 69 Gefitinib 69 chemotherapeutic agents 68 sorafenib Nexavar 68 imatinib Gleevec 68 Cisplatin 68 bortezomib Velcade 68 doxorubicin 68 paclitaxel Taxol 68 5 FU 68 interferon alfa 68 Erlotinib 68 tyrosine kinase inhibitor 68 bevacizumab Avastin 68 fulvestrant 68 anti androgen 68 liposomal formulation 67 taxanes 67 chemotherapeutic 67 proteasome inhibitor 67 idarubicin 67 trabectedin 67 docetaxel Taxotere 67 luteinizing hormone releasing 67 anticancer agents 67 anticancer agent 67 docetaxel Taxotere ® 67 lapatinib Tykerb 67 relapsed ovarian cancer 67 chemotherapeutics 67 bleomycin 67 Cytoxan 67 Pemetrexed 67 EGFR tyrosine kinase inhibitors 66 mTOR inhibitor 66 biologic therapy 66 vorinostat 66 angiogenesis inhibitor 66 docetaxel chemotherapy 66 orally bioavailable 66 anticancer therapy 66 erlotinib 66 alkylating agents 66 microtubule inhibitor 66 superficial bladder cancer 66 receptor tyrosine kinase inhibitor 66 pegfilgrastim 66 gefitinib Iressa 66 Doxorubicin 66 5 fluorouracil 66 Zolinza 66 gemcitabine 66 Dasatinib 66 Bortezomib 66 gemcitabine Gemzar 66 dasatinib Sprycel 66 nucleoside analog 66 Trabectedin 66 immunosuppressant drug 66 anti angiogenic agent 66 proteasome inhibitors 65 chemotherapies 65 EGFR inhibitors 65 BAY #-# 65 vinca alkaloid 65 taxane chemotherapy 65 tyrosine kinase inhibitors 65 nucleoside reverse transcriptase inhibitor 65 Vidaza azacitidine 65 VEGF inhibitors 65 pertuzumab 65 camptothecin 65 nucleoside analogs 65 EGFr 65 factor G CSF 65 mycophenolate mofetil 65 selective inhibitor 65 humanized monoclonal antibody 65 imatinib Gleevec ® 65 apoptotic pathway 65 immunomodulator 65 immunomodulatory 65 chimeric monoclonal antibody 65 etoposide 65 VAPRISOL 65 cilengitide 65 docetaxel Taxotere R 65 cisplatin 65 bevacizumab Avastin ® 65 enzyme inhibitor 65 cytotoxic 65 depsipeptide 65 cetuximab Erbitux ® 65 thalidomide Thalomid 65 pegylated liposomal doxorubicin 65 corticosteroid dexamethasone 65 alpha interferon 65 immunosuppressant 65 Oxaliplatin 65 PEGylated Fab fragment 65 taxol 65 PKC# 65 YONDELIS 65 targeted antifolate 65 Gleevec resistant 65 chemotherapeutic drugs 65 oral prodrug 65 somatostatin analogue 64 Interferon alpha 64 Irinotecan 64 LY# [003] 64 PARP inhibitors 64 gemcitabine chemotherapy 64 humanized anti 64 efalizumab 64 immune modulator 64 dasatinib Sprycel ® 64 erythropoietic 64 hormone LHRH 64 multi kinase inhibitor 64 5 Fluorouracil 64 mTOR inhibitors 64 gemcitabine cisplatin 64 bendamustine 64 GRN#L 64 cytotoxic agents 64 histone deacetylase HDAC inhibitor 64 TNF Tumor Necrosis Factor 64 Vidofludimus 64 Cremophor 64 EGF receptor 64 rituximab Rituxan 64 sodium glucose cotransporter 64 fluoropyrimidine 64 gastrointestinal stromal tumors GIST 64 meropenem 64 molecularly targeted 64 xanthine oxidase inhibitor 64 bortezomib 64 vinca alkaloids 64 nucleoside analogue 64 TNF inhibitor 64 taxane 64 IFN alpha 64 antibody fragment 64 ZOLINZA 64 radiation sensitizer 64 Gemzar ® 64 Taxotere docetaxel 64 platelet inhibitor 64 investigational humanized monoclonal antibody 64 Taxol paclitaxel 64 Rituxan rituximab 64 pemetrexed 64 Talabostat 64 Lenalidomide 64 gemcitabine carboplatin 64 vincristine 64 Trastuzumab 64 Sym# 64 mTOR mammalian target 64 Hycamtin 63 Omacetaxine mepesuccinate 63 liposomal doxorubicin 63 temozolomide 63 chronic lymphocytic leukemia CLL 63 humanized antibody 63 amphotericin B 63 leflunomide 63 Bevacizumab 63 metastatic renal cell carcinoma 63 GW# [003] 63 Pralatrexate 63 Tarvacin 63 trastuzumab 63 denileukin diftitox 63 Seliciclib 63 multikinase inhibitor 63 sunitinib Sutent ® 63 Voreloxin 63 chemotherapy regimens 63 interferon IFN 63 cetuximab Erbitux 63 AP# [003] 63 anticancer compound 63 uric acid lowering 63 kinase inhibitor 63 insulin sensitizing 63 histone deacetylase inhibitors 63 immune modulatory 63 selective modulator 63 Taxol ® 63 AEG# 63 HER2 receptor 63 Enzastaurin 63 antitumor effect 63 Traficet EN 63 topotecan 63 photosensitiser 63 vWF 63 MAGE A3 ASCI 63 Gemcitabine 63 HER2 positive metastatic breast 63 adriamycin 63 nilotinib Tasigna ® 63 peptide antigens 63 PI3K inhibitor 63 Ontak 63 calcineurin inhibitors 63 Pertuzumab 63 HSP# inhibitor 63 sulindac 63 5FU 63 enzastaurin 63 Mitoxantrone 63 Amrubicin 63 paclitaxel Taxol ® 63 ixabepilone 63 antisense oligonucleotide 63 peripheral neuropathy CIPN 63 sorafenib 63 cell lymphoma CTCL 63 IAP inhibitor 63 sorafenib tablets 63 xenograft models 63 bevacizumab 63 interferon alpha 63 Certolizumab pegol 63 Azedra 63 CHOP chemotherapy 63 dacarbazine 63 Nexavar ® 63 IgG1 monoclonal antibody 63 immune modulating 62 bortezomib Velcade ® 62 Aplidin 62 immune modulators 62 sphingosine 1 62 temsirolimus 62 cyclophosphamide 62 Carboplatin 62 Fludarabine 62 Akt activation 62 SERMs 62 immunosuppressive regimen 62 gamma secretase inhibitor 62 ganciclovir 62 sorafenib Nexavar ® 62 gamma secretase inhibitors 62 retinoid 62 pan HDAC inhibitor 62 factor TNF 62 PARP inhibitor 62 anthracyclines 62 chemotherapeutic regimens 62 Doxil ® 62 histone deacetylase HDAC inhibitors 62 adjuvant therapy 62 Faslodex 62 hormone LHRH antagonist 62 tyrosine kinase inhibitors TKIs 62 Vandetanib 62 epithelial tumors 62 Cetuximab 62 selective inhibition 62 MGd 62 visilizumab 62 beta2 agonist 62 differentiated thyroid 62 intravenously administered 62 insulin sensitizers 62 nucleoside analogues 62 imatinib mesylate 62 Glucocorticoids 62 DACH platinum 62 pro apoptotic 62 recurrent glioblastoma multiforme 62 eflornithine 62 Cyclosporine 62 lupus nephritis 62 angiotensin receptor blocker ARB 62 Atrasentan 62 PLX# 62 chemoresistance 62 Torisel 62 bicalutamide 62 calcitriol 62 Bleomycin 62 docetaxel 62 Laquinimod 62 selective agonist 62 Velcade bortezomib 62 CA4P 62 alefacept 62 Paraplatin ® 62 surrogate endpoint 62 gastrointestinal stromal tumor GIST 62 immunomodulators 62 TNFa 62 receptor antagonists 62 TKIs 62 EGFR pathway 62 proteasome inhibitor bortezomib 62 cediranib 62 drug zotarolimus 62 Combination therapy 62 CYC# 62 sirolimus 62 Tumor Necrosis Factor 62 BRAF inhibitors 62 trastuzumab Herceptin 62 acute promyelocytic leukemia APL 62 dexamethasone Decadron 62 small molecule Hedgehog 62 anti EGFR antibody 62 OncoVEX GM CSF 62 VEGF receptor 62 VA# [002] 62 cytostatic 62 tenofovir Viread 62 Everolimus 62 epirubicin 62 factor Xa inhibitor 62 chlorambucil 62 Vorinostat 62 anti leukemic 62 PRT# 62 standard chemotherapy regimens 62 cetuximab Erbitux R 62 NMDA antagonist 62 Dapagliflozin 62 MEK inhibitors 62 doxorubicin Adriamycin 62 IAP inhibitors 62 Tamibarotene 62 Abatacept 62 metastatic neuroendocrine tumors 62 photodynamic therapy 62 APTIVUS r 62 Aliskiren 62 hormone agonist 62 trans retinoic acid ATRA 62 androgen receptor AR 62 immunomodulatory therapy 62 vinorelbine 62 Temsirolimus 62 thymalfasin 62 CDDO Im 62 azacitidine 62 Doxil 62 somatostatin analogues 62 alkylating 62 ISTODAX 62 immunotherapeutic agent 62 selective kinase inhibitor 62 PNP inhibitor 62 Aurora kinase 62 G CSF 62 LHRH agonist 62 HGS# 62 trans retinoic acid 62 GM CSF 62 oral antiviral 62 protein kinase inhibitor 62 standard chemotherapy regimen 62 Taxotere ® 62 tumor xenograft models 62 MEK inhibitor 62 factor Xa 62 Xanafide 62 anti angiogenic drugs 61 polymerase inhibitor 61 Taxanes 61 CBLC# 61 Epratuzumab 61 solid tumors 61 cyclophosphamide Cytoxan 61 anti CD3 antibody 61 Preclinical studies suggest 61 Sorafenib Nexavar 61 potent inhibitor 61 PI3K/Akt pathway inhibitor 61 decitabine 61 Ceflatonin 61 Bendamustine 61 letrozole Femara 61 anti angiogenic 61 TACE 61 lenalidomide Revlimid R 61 receptor inhibitor 61 small molecule tyrosine 61 rituximab 61 seliciclib 61 hypoxia inducible factor 61 ganetespib 61 immunotoxins 61 ADP receptor antagonist 61 cisplatin chemotherapy 61 teriflunomide 61 CDK inhibitor 61 novel peptide 61 trastuzumab Herceptin ® 61 selective antagonist 61 antitumor activity 61 antifolate 61 Pathway Inhibitor 61 fluoroquinolone antibiotic 61 HuMax CD4 61 Smac mimetic 61 Rituximab 61 Sorafenib 61 Vaprisol 61 Neulasta ® 61 interferon alfa 2b 61 Erbitux cetuximab 61 antimetabolite 61 antiangiogenic 61 idraparinux 61 anthracycline taxane 61 Cytarabine 61 injectable formulation 61 IMiDs R 61 TREANDA 61 AMN# [001] 61 IGF IR 61 leukemia AML 61 fluorouracil 61 investigational compound 61 protease inhibitor 61 imatinib resistant 61 modulator SERM 61 HDACi 61 HGS ETR1 61 Carfilzomib 61 alpha folate receptor 61 prodrug 61 Deforolimus 61 interferon therapy 61 Camptosar ® irinotecan 61 Bezielle 61 cidofovir 61 FOLFIRI 61 #HT#A 61 induces apoptosis 61 Linaclotide 61 Zoledronic acid 61 alpha interferons 61 amrubicin 61 CD# antibody [001] 61 Denufosol 61 BCR ABL 61 Genasense ® 61 canakinumab 61 LY# [002] 61 mitomycin 61 vandetanib 61 paclitaxel Taxol R 61 HCV protease 61 antithrombotic 61 immunomodulating 61 colon carcinoma 61 MTP inhibitor 61 imatinib 61 oxaliplatin 61 Bone Morphogenetic Protein 61 Tyrima 61 5 FU leucovorin 61 HuMax EGFr 61 LHRH 61 Ixempra 61 bortezomib Velcade R 61 IMA# 61 cytotoxic chemotherapy 61 HuLuc# 61 tubulin binding 61 chemically modified siRNA 61 cetuximab 61 Riluzole 61 anticancer 61 protein mTOR 61 Darinaparsin 61 EGFR TKI 61 Platinol 61 sunitinib 61 gastrointestinal stromal tumor 61 immunoconjugate 61 forodesine 61 interferons 61 metastatic colorectal 61 mRCC 61 targeted radiotherapeutic 61 panitumumab Vectibix 61 tiotropium bromide 61 anticancer drugs 61 cisplatin carboplatin 61 leucovorin 61 Platinol ® cisplatin 61 metastatic malignant 61 myelofibrosis polycythemia vera 61 Orally administered 61 Oral corticosteroids 61 induce apoptosis 61 paclitaxel chemotherapy 61 Telmisartan 61 granisetron 61 Androgen deprivation therapy 61 active metabolite 61 busulfan 61 inhibitor RG# 61 Fingolimod 61 filgrastim 61 Natalizumab 61 Fludara 61 Gleevec imatinib 61 intratumoral injection 61 pegylated 60 nucleotide analogue 60 Amplimexon 60 PEGylated anti 60 polycythemia vera PV 60 metaglidasen 60 systemically administered 60 daunorubicin 60 thrombopoietin 60 IFN beta 60 Docetaxel 60 entinostat 60 antitumor 60 Maribavir 60 potent topoisomerase II 60 cytochrome P# #A# 60 administered subcutaneously 60 Bicalutamide 60 T#I [002] 60 Tarceva TM 60 pharmacokinetic interactions 60 Topotecan 60 EGFR 60 cytotoxicity 60 paclitaxel 60 anti CD3 60 Elvitegravir 60 malignant pleural mesothelioma 60 Paclitaxel 60 Belimumab 60 intravenous bisphosphonates 60 gonadotropin releasing hormone GnRH 60 tanespimycin 60 inhibitor PPI 60 Camptosar ® 60 regorafenib 60 antibody MT# 60 FOLFOX chemotherapy 60 Teysuno 60 histone deacetylase inhibitor 60 systemic RNAi therapeutic 60 basiliximab 60 HGS ETR2 60 prostate cancer HRPC 60 anti thrombotic 60 lanreotide 60 imetelstat 60 Liposomal 60 cytotoxics 60 Zorbtive TM 60 recurrent ovarian cancer 60 demethylating agent 60 fibrinolytic 60 anticancer therapies 60 humanised monoclonal antibody 60 poly ADP ribose polymerase 60 Etoposide 60 LEP ETU 60 immune stimulatory 60 direct thrombin inhibitor 60 neuroprotectant 60 effector function 60 infliximab Remicade 60 deacetylase inhibitors 60 Zarnestra 60 generation purine nucleoside 60 CEQ# 60 paricalcitol 60 humanized monoclonal antibodies 60 aldosterone antagonists 60 quinolone 60 Herceptin trastuzumab 60 OPAXIO 60 Smac mimetics 60 CANCIDAS 60 resistant ovarian cancer 60 Amphinex ® 60 neratinib 60 carboplatin paclitaxel 60 estrogen receptor antagonist 60 DOXIL 60 antiproliferative 60 intravesical instillation 60 oxidative stress inducer 60 long acting muscarinic 60 gastrin 60 JAK inhibitor 60 XmAb# 60 DHFR 60 subcutaneous formulation 60 investigational antibody 60 chemotherapeutic regimen 60 Factor VIIa 60 photosensitizer 60 protease inhibitors 60 tocilizumab 60 Temozolomide 60 glioma cells 60 mecamylamine 60 MGCD# [001] 60 integrase inhibitor 60 mTOR kinase 60 Vicinium TM 60 estramustine 60 lenalidomide dexamethasone 60 EpCAM 60 Abiraterone acetate 60 CD3 monoclonal antibody 60 ENMD # 60 Blinatumomab 60 boosted protease inhibitor 60 advanced metastatic renal 60 TNF antagonists 60 drug DMARD 60 angiotensin II receptor blocker 60 overlapping toxicities 60 DPP4 60 fluvastatin 60 lapatinib 60 hormone LHRH agonist 60 chemotherapy regimen 60 Imatinib mesylate 60 protein tyrosine phosphatase 1B 60 PXD# 60 oral anticoagulant 60 octreotide acetate 60 echinocandins 60 Tarceva erlotinib 60 IMiDs ® compound 60 T#I mutant 60 glucocorticoids 60 Degarelix 60 LHRH antagonist 60 elotuzumab 60 IMiDs ® 60 acetylcholinesterase AChE 60 vinblastine 60 caspofungin 60 Nanobody 60 ATL# [001] 60 protease inhibitor PI 60 albumin bound paclitaxel 60 Imprime PGG 60 chemopreventive agent 60 anti secretory 60 antifungal agent 60 NF kB pathway 60 vascular disrupting agent 60 AKT inhibitor 60 TRAIL R2 60 monotherapy 60 endocrine therapies 60 mertansine 60 Photodynamic therapy PDT 60 liposomal amphotericin B 60 RoACTEMRA 60 CLL cells 60 Maraviroc 60 mycophenolic acid 60 anti proliferative 60 organ transplant rejection 60 laropiprant 60 antiplatelet agent 60 histone deacetylases 60 steroid prednisone 60 ifosfamide 60 BRAF inhibitor 60 GPIIb IIIa 60 selectively inhibit 60 leukemia CLL 60 HIV protease inhibitor 60 p# inhibitors 60 novel immunomodulatory 60 Epidermal Growth Factor Receptor 60 human monoclonal antibody 60 indibulin 60 Imiquimod 60 tigecycline 60 rituximab Rituxan ® 60 pentamidine 60 Abacavir 60 Ganciclovir 60 CCR2 60 BMS # 60 formoterol fumarate 60 MetMAb 60 carboplatin 60 tumor antigen 60 Fc fusion protein 60 SGLT2 inhibitors 60 EGFR TKIs 60 Genentech Rituxan 60 SERCA2a 60 relapsing multiple sclerosis 60 Epirubicin 60 forskolin 60 Pazopanib 60 erythropoiesis stimulating agent 60 Dabigatran etexilate 60 hepatoma 60 dasatinib 60 PEGylated 60 antiemetics 60 glioblastoma multiforme GBM 60 octreotide LAR 60 Epothilones 60 receptor antagonist 60 gastrointestinal stromal tumors GISTs 60 cytarabine 60 sulodexide 60 Vinorelbine 59 HER2/neu 59 Kinoid 59 zoledronate 59 Neupogen ® 59 nephrotoxicity 59 Hsp# inhibitors 59 hematological malignancies 59 WT1 59 SCCHN 59 Capecitabine 59 abacavir lamivudine 59 cisplatin resistant 59 Pegasys ® 59 itraconazole 59 monoclonal anti 59 Gleevec imatinib mesylate 59 Imatinib 59 inhaled formulation 59 zalutumumab 59 temozolomide Temodar 59 axitinib 59 cyclophosphamide methotrexate 59 Avastin bevacizumab 59 azole 59 IMGN# 59 Leukine ® 59 heparins 59 B7 H3 59 colony stimulating factors 59 direct thrombin inhibitors 59 Gliadel Wafer 59 nab paclitaxel 59 immunosuppressive therapies 59 interferon 59 TNFα 59 Tacrolimus 59 TRPV1 agonist 59 mutated KRAS gene 59 synthetic peptide 59 Telintra 59 ELOXATIN 59 OMP #R# 59 chemoradiotherapy 59 hematologic malignancies 59 echinocandin 59 Quinamed 59 injected subcutaneously 59 TNF α 59 Ceplene/IL-2 59 novel topoisomerase 59 raltegravir 59 microwave hyperthermia 59 salmeterol fluticasone 59 psoralen 59 INCB# [002] 59 flavopiridol 59 TREDAPTIVE 59 monoclonal antibody 59 NFkB 59 mitoxantrone 59 pemetrexed Alimta 59 castration resistant prostate cancer 59 HCD# [002] 59 HMG CoA reductase inhibitors 59 pazopanib 59 Hedgehog signaling pathway 59 posaconazole 59 Onconase 59 anticancer treatments 59 huC# DM4 59 zoledronic acid 59 cyclosporin 59 active moiety 59 PDE4 inhibitor 59 Vidaza ® 59 CCR5 inhibitor 59 obatoclax 59 JAK inhibitors 59 non squamous NSCLC 59 HER2 antibody 59 polyethylene glycol PEG 59 FUSILEV enhances 59 CTLA 4 59 orally dosed 59 conventional DMARDs 59 tipifarnib 59 refractory ovarian cancer 59 lipid lowering therapies 59 kinase inhibitors 59 gastrointestinal stromal tumors 59 DU #b 59 Tumour Necrosis Factor 59 Methylnaltrexone 59 nicotinic acid 59 Transdrug ® nanoparticle 59 PI3 kinase inhibitors 59 Interferon beta 59 vascular disrupting agents 59 long acting bronchodilator 59 Taxotere R 59 topoisomerase II inhibitor 59 anti angiogenic agents 59 administered orally 59 Debio 59 LHRH agonists 59 thrombin receptor 59 HGS ETR1 mapatumumab 59 panobinostat 59 CXCR4 59 Interferon alfa 59 Dacogen decitabine 59 antiandrogen 59 SCH # 59 immunosuppressive 59 ligand TRAIL 59 milatuzumab 59 rFIXFc 59 myelosuppression 59 aminoglycoside 59 sunitinib malate 59 IGF 1R 59 ALK inhibitor 59 temsirolimus Torisel ® 59 azelaic acid 59 doublet chemotherapy 59 androgen independent 59 NNRTIs 59 demethylating agents 59 APTIVUS 59 octreotide 59 reslizumab 59 ErbB3 59 cytotoxin 59 bone metastasis 59 topical antifungal 59 ritonavir boosted 59 ISF# 59 FOLFOX6 59 imatinib therapy 59 azacytidine 59 paroxetine Paxil 59 Halaven 59 cytoprotective 59 Platinol ® 59 CYP #A# 59 FTY# 59 immunotoxin 59 adalimumab Humira 59 Onalta 59 cyclic peptide 59 AQ4N 59 inhibitory effects 59 K ras mutations 59 potent anticancer 59 cutaneous T 59 Nexavar sorafenib 59 biomodulator 59 myeloma cells 59 EndoTAGTM 1 59 cinacalcet 59 CD# monoclonal antibody 59 TEMODAL 59 EGFR antibodies 59 Photodynamic therapy 59 aromatase inhibitor 59 tamoxifen Nolvadex ® 59 anthracycline chemotherapy 59 N acetylcysteine 59 FGFR 59 Granulocyte Colony Stimulating Factor 59 thymidylate synthase TS 59 zoledronic acid Zometa 59 synthetic retinoid 59 PI3K inhibitors 59 exemestane Aromasin 59 zidovudine AZT 59 NKG2D 59 Etanercept 59 peripherally acting 59 Pixantrone 59 dihydrochloride 59 Corticosteroids 59 SCIg 59 recombinant tissue plasminogen 59 verteporfin 59 Alpharadin 59 cardiotoxic 59 colorectal carcinoma 59 Raltegravir 59 endostatin 59 Lisofylline 59 GnRH agonist 59 ACZ# 59 endoxifen 59 BRAF mutation 59 liposome encapsulated 59 Valproic acid 59 CYP#A# inhibitors 59 IgG1 antibody 59 castration resistant 59 irreversible inhibitor 59 antineoplastic 59 chemotherapeutic treatments 59 investigational drug 59 Bcr Abl 59 Omacetaxine 59 indolent NHL 59 immunosuppressive agents 59 romidepsin 59 DMARD 59 Panitumumab 59 curcuminoids 59 gefitinib 59 systemic antifungal 59 Votrient 59 TYZEKA 59 neoadjuvant chemotherapy 59 Darunavir 59 avidin 59 BN# [002] 59 liposome formulation 59 irinotecan 59 Jevtana 59 adecatumumab 59 TNFalpha 59 basal cell carcinoma BCC 59 renin inhibitor 59 Romiplostim 59 CCX# 59 Abl 59 antiarrhythmic 59 Xcytrin 59 receptor agonist 59 sPLA2 59 GSTP1 59 Celecoxib 59 metastatic colorectal cancer 59 3TC lamivudine Epivir 59 highly selective inhibitor 59 Factor Xa inhibitor 59 Hydroxyurea 59 Proxinium TM 59 hematological cancers 59 inhibit VEGF 59 granulocyte colony stimulating 59 calcineurin inhibitor 59 colorectal cancer liver metastases 59 FUS1 59 AVASTIN 59 sodium stibogluconate 59 Elesclomol 59 hepatocellular carcinoma HCC 59 orally administered inhibitor 59 BiTE 59 VEGFb 59 Melphalan 59 pralatrexate 59 subcutaneously administered 59 eltrombopag 59 systemic lupus erythematosus SLE 59 Nilotinib 59 accumulate preferentially 59 INCB# [003] 59 potent cytotoxic 59 investigational oral 59 iniparib 59 vidofludimus 59 hypercalcemia 59 Panzem R